The institute's scientific advisory board

To ensure a high quality of research is maintained over the long term, all Max Planck Institutes are subject to regular assessment from independent scientific advisory boards (SAB). For each institute, the board is composed of experts from leading international research institutions and universities of the respective research field. The board members are selected by the president of the Max Planck Society on the basis of suggestions from the institutes. They are elected to the board for a maximum term of six years.

The Max Planck Institute of Neurobiology's scientific advisory board is composed of the following scientists:

• Prof. Dr. Paola Arlotta
  Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, USA

• Prof. Dr. Claudia Bagni Département des neurosciences fondamentales, Université de Lausanne, Lausanne, Switzerland

• Prof. Dr. Yang Dan, 
  Department of Molecular & Cell Biology, University of California, Berkeley, USA

• Prof. Dr. Catherine Dulac
  Department of Molecular and Cellular Biology, Harvard University, Cambridge, USA

• Prof. Dr. Liqun Luo
  Department of Biological Sciences, Stanford University, Stanford, USA

• Prof. Dr. Oscar Marin 
  MRC Centre for Developmental Neurobiology, King’s College London, London, UK

• Prof. Dr. J. Anthony Movshon
  Center for Neural Science, New York University, New York, USA

• Prof. Dr. Hitoshi Okamoto,
  RIKEN Center for Brain Science, Saitama, Japan

• Prof. Dr. Botond Roska
  Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland